share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

SEC announcement ·  Jun 25 16:18
Summary by Moomoo AI
James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
James F. Young, associated with Novavax Inc [NVAX], completed a sale of 7,500 shares of common stock on June 21, 2024. The transaction was carried out in the open market with the shares sold at a price of $14.09 each, resulting in a total sale value of $105,675. Following the sale, Young's direct holdings in Novavax common stock amount to 61,760 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more